The Growing Role of Telehealth in Diabetes Care During Flu Season

For individuals living with diabetes, the arrival of flu season brings heightened concern. The immune system of a person with diabetes is often compromised, making them more vulnerable to respiratory infections like influenza. At the same time, the flu can cause dangerous fluctuations in blood glucose levels, increasing the risk of diabetic ketoacidosis and other acute complications. Traditionally, managing these intersecting risks required frequent in-person visits to endocrinologists, primary care physicians, and diabetes educators. However, the convergence of a global pandemic and seasonal influenza has accelerated the adoption of telehealth as a safe, effective, and often superior alternative. Telehealth has transformed how patients with diabetes receive care during flu season, offering continuous support while minimizing exposure to pathogens. This article explores the specific ways telehealth addresses the unique challenges of diabetes management when flu risk is high, the evidence supporting its use, practical implementation strategies, and the road ahead for this rapidly evolving care model.

The Unique Intersection of Diabetes and Influenza

Influenza is not just a nuisance for people with diabetes — it is a serious threat. Studies consistently show that adults with diabetes are significantly more likely to be hospitalized with flu-related complications compared to those without diabetes. The Centers for Disease Control and Prevention (CDC) lists diabetes as a high-risk condition for severe flu illness. Hyperglycemia impairs immune function, reduces the body’s ability to clear viruses, and promotes a pro-inflammatory state that exacerbates flu symptoms. Conversely, the flu virus can directly disrupt glucose metabolism through stress hormone release, leading to unpredictable highs and lows. Managing these dynamics requires careful monitoring, medication adjustments, and timely clinician input — all of which become more challenging when in-person visits are risky or inconvenient.

The flu season further amplifies barriers to routine care. Busy clinics fill with contagious patients, wait times increase, and patients may delay seeking help for fear of exposure. This creates a dangerous gap in care for those who need ongoing glucose tracking, insulin dose titration, and education about sick-day rules. Telehealth bridges this gap by enabling remote consultations, continuous glucose monitoring (CGM) data sharing, and medication management without the patient ever entering a waiting room.

How Telehealth Addresses Key Diabetes Management Challenges During Flu Season

Reducing Exposure Without Sacrificing Care Quality

The most obvious benefit of telehealth during flu season is infection control. Virtual visits replace in-person appointments for many routine encounters — follow-ups for HbA1c review, medication refills, and basic troubleshooting. This dramatically reduces the patient’s contact with potentially infected individuals. A systematic review published in the Journal of Diabetes Research found that telehealth interventions for diabetes resulted in comparable or better glycemic outcomes than usual care, while simultaneously lowering clinic traffic. By keeping vulnerable patients out of crowded healthcare settings, telehealth directly reduces flu transmission risks.

Real-Time Continuous Glucose Monitoring and Remote Data Sharing

One of the most powerful components of modern diabetes telehealth is the integration of continuous glucose monitoring (CGM) systems. Devices like the Dexcom G6, Abbott FreeStyle Libre, and Medtronic Guardian Connect allow patients to stream glucose data directly to their care team via cloud-based platforms. During a telehealth visit, the clinician can review the patient’s sensor trace, identify patterns of hyperglycemia or hypoglycemia, and make immediate recommendations for insulin dose adjustments or dietary changes. This capability is especially critical during flu season because illness can cause sudden and severe glucose swings. Without remote monitoring, a patient might wait days for an appointment — by which time dangerous ketoacidosis could have developed. With telehealth and CGM, the care team can intervene within hours.

Enhanced Sick-Day Management Protocols

Every person with diabetes should have a written sick-day plan for managing glucose during illness. Telehealth makes it easier for clinicians to deliver and reinforce these plans in real time. During a virtual visit, the provider can walk through the patient’s home supplies — ketone strips, insulin, glucose tabs — and check that the patient understands when to use correction doses and when to seek emergency care. Many telehealth platforms also allow asynchronous messaging, so a patient can send a quick update about elevated glucose or nausea and receive guidance without scheduling a full video call. A 2021 study in Diabetes Technology & Therapeutics reported that patients who used telehealth-based sick-day coaching during flu season had a 40% lower rate of emergency department visits compared to those who relied on standard clinic follow-up.

Medication Management and Prescription Refills

Flu season often coincides with insurance coverage gaps and pharmacy delays. Telehealth enables clinicians to efficiently review medication lists, check for drug interactions (e.g., between antivirals like oseltamivir and insulin), and send electronic prescriptions to the patient’s pharmacy. For patients using insulin pumps or smart pens, virtual visits allow clinicians to download pump history, adjust basal rates, and modify bolus settings — all without a hospital visit. This streamlined approach ensures that patients maintain optimal therapy throughout the season, reducing the risk of both hyperglycemia and hypoglycemia.

Patient Education and Behavioral Support

Diabetes self-management education (DSME) is a cornerstone of effective care, but traditional in-person classes often pause during flu season due to low attendance and infection concerns. Telehealth platforms offer a flexible alternative. Live group classes via Zoom, on-demand video modules, and one-on-one coaching sessions allow patients to continue learning about carbohydrate counting, insulin timing, and sick-day rules. Moreover, behavioral health is a critical component — many patients experience diabetes distress and anxiety during flu season. Telehealth facilitates remote counseling with psychologists or social workers who specialize in diabetes, helping patients maintain mental well-being and treatment adherence.

Evidence Supporting Telehealth for Diabetes During Flu Season

Multiple high-quality studies confirm the efficacy of telehealth for diabetes management, particularly during respiratory illness outbreaks. A meta-analysis from the Cochrane Library reviewed 24 randomized controlled trials involving over 8,000 patients and found that telehealth interventions produced a statistically significant reduction in HbA1c (approximately -0.3% to -0.5%) compared to usual care, with the greatest improvements seen in patients who used remote monitoring and frequent virtual check-ins. Another study conducted during the COVID-19 pandemic (which overlapped with flu seasons in 2020-2022) examined a cohort of patients with type 1 diabetes who switched to telehealth-based CGM review. The researchers reported that time-in-range (TIR) remained stable or improved, and severe hypoglycemia events actually declined — likely because clinicians were able to adjust therapy more nimbly through remote data review than through sporadic office visits.

Furthermore, patient satisfaction with telehealth remains high. Surveys indicate that more than 85% of patients with diabetes find telehealth convenient, and a majority prefer to continue using it for routine follow-ups even after pandemic restrictions eased. This is particularly relevant for rural populations and those with limited mobility, who often struggle to access endocrinology care during flu season. Telehealth eliminates travel barriers and extends specialist expertise to underserved areas.

Addressing the Challenges: Practical Considerations for Providers and Patients

Digital Divide and Technology Access

Despite these advantages, telehealth is not a panacea. Significant disparities persist in access to broadband internet, smartphones, and digital literacy. Older adults — who make up a large proportion of the diabetes population — may struggle with video platforms or CGM data sharing. Health systems must invest in patient support: providing loaner devices, offering telephone-only visits as a bridge, and training staff to troubleshoot basic technical issues. The American Diabetes Association recommends that telehealth programs include a “digital health navigator” to assist patients with onboarding. Without these safeguards, telehealth risks widening health inequities.

Limitations of Virtual Physical Examination

Certain aspects of diabetes care cannot be fully replicated remotely. For example, foot exams to detect neuropathy, skin inspection for injection site infections, and blood pressure measurement require physical presence or peripheral devices. However, many clinicians are developing hybrid models: a patient may have one in-person visit per year for comprehensive screening (including lab draws and foot exams) while all other follow-ups are telehealth. For acute issues during flu season, providers can often make triage decisions based on patient report, CGM data, and home-monitored vitals. Clear protocols should define when an in-person visit is mandatory — such as suspected foot ulcers, severe dehydration, or mental status changes.

Reimbursement and Regulatory Hurdles

Telehealth reimbursement policies vary by state and insurer, though the pandemic prompted Medicare and many private insurers to expand coverage for virtual diabetes services. During flu season, it is critical that patients understand their plan’s telehealth benefits, co-pays, and coverage for remote monitoring devices. Clinicians should verify that their state medical board allows cross-state telehealth visits for follow-up care, as many patients travel during flu season or have moved temporarily. Advocacy groups continue to push for permanent reimbursement parity, which would further solidify telehealth’s role in seasonal disease management.

Ensuring Continuity Across Episodes

One underappreciated challenge is coordinating care when a patient becomes acutely ill with the flu while simultaneously managing diabetes. Telehealth visits should include a discussion of contingency plans: what to do if the patient’s glucose monitor fails, who to call if they develop vomiting, and how to adjust long-acting insulin during periods of poor appetite. Some telehealth platforms now integrate with electronic health records (EHRs) to automatically flag high-risk patients during flu season, triggering proactive outreach. For example, if a patient with type 1 diabetes has missed a scheduled telehealth visit, the system can send a nurse-led phone check-in. These automated workflows help close the loop and prevent decompensation.

Building a Telehealth-Ready Diabetes Management Plan for Flu Season

Pre-Season Preparation

The most successful telehealth interventions begin before flu season hits. A robust plan includes:

  • Ensuring device compatibility: Confirm that the patient’s CGM, insulin pump, or smart pen can sync with the clinic’s remote monitoring platform. Provide clear instructions or a test run.
  • Setting up a shared calendar: Schedule all routine telehealth visits for the next three months, with reminders sent via text or email.
  • Stocking supplies: Use a virtual visit to verify that the patient has enough test strips, ketone strips, insulin, glucagon, and sick-day supplies to last through peak flu season.
  • Creating a written sick-day action plan: Print or email a personalized plan that lists blood glucose targets, insulin adjustment rules, when to use ketone testing, and emergency numbers. Review it together during a telehealth appointment.

During the Visit

Clinicians should structure each telehealth session for maximum efficiency. A typical flu-season diabetes follow-up might cover:

  1. Review of CGM data or self-monitored blood glucose logs over the past 1-4 weeks.
  2. Inquiry about recent infections, fever, or gastrointestinal symptoms.
  3. Medication reconciliation (including over-the-counter cold medications that may affect glucose).
  4. Physical exam elements that can be done at home (patient-guided foot inspection using a mirror or smartphone camera, blood pressure reading from a home monitor).
  5. Reinforcement of sick-day rules and vaccination status (remind about annual flu shot).
  6. Agreement on next steps: medication changes, lab orders, referral to in-person visit if indicated.

Post-Visit Support

After the telehealth visit, the care team should ensure the patient has follow-up contact information. Many clinics now employ diabetes care and education specialists (DCES) who can provide between-visit support via secure messaging or phone calls. For patients using insulin pumps, a remote pump download review can be done weekly during flu season to catch silent hypoglycemia. Automated text-message programs that prompt patients to check blood glucose or submit daily symptoms are also effective. A study conducted at the Mayo Clinic found that daily text check-ins during flu season reduced hospitalizations for diabetic ketoacidosis by 30%.

The Future of Telehealth and Diabetes Care Through Flu Season and Beyond

The pandemic has permanently shifted the landscape of diabetes care. Hybrid models that blend telehealth with occasional in-person visits are now considered standard of care by many professional societies. Advancements in artificial intelligence are poised to make telehealth even more impactful. Machine learning algorithms can analyze CGM data in real time and predict when a patient is likely to experience a significant glucose derangement, prompting an automated virtual check-in. Wearable sensors that track temperature, heart rate, and activity level could provide early warning of flu infection before symptoms are noticeable.

Policy changes are also on the horizon. The U.S. government and many state legislatures are considering bills to permanently extend telehealth flexibilities that were enacted during the public health emergency. If passed, these laws would ensure that patients with diabetes can continue to receive remote care for chronic disease management, including during annual flu seasons. Additionally, integrated platforms that unify CGM, insulin pumps, and telehealth video visits into a single patient-facing app will reduce friction and improve adherence.

Practical Recommendations for Patients and Providers

For Patients

  • Get your annual flu shot — ideally before flu season begins. Telehealth can be used to schedule the vaccine appointment or confirm that it was received.
  • Test your technology: Ensure your internet connection, camera, microphone, and CGM sharing app work at least one week before your first scheduled telehealth visit.
  • Keep a written log of symptoms, glucose readings, food intake, and medication changes. Share it during your virtual visit.
  • Ask about remote monitoring: If you don’t already use a CGM, ask your provider if it’s appropriate for you, especially during flu season.
  • Know your sick-day numbers: Write down your target blood glucose, the level at which you should test for ketones, and when to call your provider or go to the ER.

For Providers

  • Standardize telehealth intake: Use a template that includes CGM download review, infection screen, medication check, and vaccination status.
  • Train staff on technical support: Dedicate at least one team member to help patients connect devices and troubleshoot platform issues.
  • Collaborate with pharmacies: Set up electronic prescription workflows so that medication adjustments made during a telehealth visit are filled promptly.
  • Develop a callback system: For patients who screen positive for flu-like symptoms during a telehealth visit, ensure a clinician follows up within 24 hours to adjust diabetes management and coordinate antiviral therapy if needed.
  • Use outcome metrics: Track HbA1c, time-in-range, and emergency department utilization during flu season to measure the effectiveness of your telehealth program.

Conclusion

Telehealth is not merely a stopgap measure for flu season — it is a transformative tool that addresses vulnerabilities inherent in traditional diabetes care. By enabling remote monitoring, virtual sick-day coaching, and continuous medication management, telehealth helps patients with diabetes navigate the heightened risks of influenza without sacrificing quality or safety. The evidence is clear: when implemented thoughtfully, telehealth can improve glycemic control, reduce hospitalizations, and enhance patient satisfaction. As technology and policy continue to evolve, the integration of telehealth into routine diabetes care will only deepen, making it an indispensable part of managing this chronic condition during flu season and every season. The responsibility now lies with healthcare systems, insurers, and policymakers to ensure that these benefits reach all patients equitably.